Betta Pharmaceuticals Co., Ltd. (SHE: 300558)
China
· Delayed Price · Currency is CNY
47.39
-1.12 (-2.31%)
Nov 15, 2024, 3:04 PM CST
Betta Pharmaceuticals Company Description
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China.
The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer.
The company was founded in 2003 and is headquartered in Hangzhou, China.
Betta Pharmaceuticals Co., Ltd.
Country | China |
Founded | 2003 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,961 |
CEO | Lieming Ding |
Contact Details
Address: No. 355, Xingzhong Road Hangzhou, 311100 China | |
Phone | 86 57 1892 65665 |
Website | bettapharma.com |
Stock Details
Ticker Symbol | 300558 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100002DD9 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Lieming Ding | Founder, Chairman of the Board of Directors, Chief Executive Officer and GM |
Jianxun Fan | Vice President, Chief Financial Officer and Director |
Jiang Wan | Senior Vice President, Chief Operating Officer and Director |
Lingxi Wu | Board Secretary and Head of Chairman Office |
Dr. Yinxiang Wang | President |
Dr. Wenxin Xu | Senior Director and Head of Immunology |
Feng Liu | Vice President |
Hena Shi | Vice President |
Yunyan Hu | Vice Director of Novel Drug Research & Development Center |